Casper Beijst

Casper Beijst

Auto-generated profile, based on publicly available information

Casper Beijst

Department of Radiotherapy, Imaging & Oncology Division, UMC Utrecht, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2015 in Journal of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
CBCasper Beijst
Casper Beijst
JKJakob Willem Kist
Jakob Willem Kist
MEMattijs Elschot
Mattijs Elschot
MVMax A. Viergever
Max A. Viergever
OHOtto S. Hoekstra
Otto S. Hoekstra
HJHugo W.A.M. de Jong
Hugo W.A.M. de Jong
Radioiodine therapy with 131I is used for treatment of suspected recurrence of differentiated thyroid carcinoma. Pre-therapy 124I PET/CT with a low activity (~1% of 131I activity) can be performed to determine whether uptake of 131I, and thereby the desired therapeutic effect, may be expected. However, false negative 124I PET/CTs as compared with the post-therapy 131I SPECT/CTs have been reported by several groups. The purpose of this study was to investigate whether the reported discrepancies may be ascribed to a difference in detectability of lesions on 124I PET/CT and 131I SPECT/CT, and hence, to determine whether the administered activity of 124I is sufficient to achieve equal detectability. Methods: Phantom measurements were performed using the NEMA-2007 image quality phantom. As a measure of detectability the contrast-to-noise ratio (CNR) was calculated. The 124I activity concentration was expressed as a percentage of the 131I activity concentration required to achieve the same CNR. This metric was defined as the detectability equivalence percentage (DEP). Results: Lower DEPs were obtained for smaller spheres, so that a relatively low 124I activity concentration is sufficient to achieve a similar detectability of lesions with 124I PET/CT as with 131I SPECT/CT. The DEP was 1.5, 1.9, 1.9, 4.4, 9.0 and 16.2% for the spheres with a diameter of 10, 13, 17, 18, 25 and 37 mm respectively, for attenuation and scatter corrected SPECT versus point spread function (PSF) modeled and time-of-flight (TOF) PET. For no-PSF no-TOF PET, the DEP was 3.6, 2.1, 3.5, 7.8, 15.1 and 23.3%. Conclusion: A relatively low activity of 74 MBq 124I (~1% of 131I activity) is sufficient to achieve similar detectability of lesions on 124I PSF TOF PET/CT and 131I SPECT/CT for small spheres (≤10mm), since the reported DEPs are close to 1%. False negative 124I PET/CTs as compared with the post-therapy 131I SPECT/CTs may be ascribed to differences in detectability for large lesions (>10mm) and for no-PSF no-TOF PET, since DEPs are larger than 1%. Based on DEPs of 3.5% for lesion diameters up to 17mm on no-PSF no-TOF PET, activities as high as 170 MBq of 124I may be warranted to obtain equal detectability.

17 April 2017 in Medical Physics
Verified
Journal Article
Closed access
PDF file
CBCasper Beijst
Casper Beijst
BKBart De Keizer
Bart De Keizer
MLMarnix G.E.H. Lam
Marnix G.E.H. Lam
GJGeert O. Janssens
Geert O. Janssens
GTGodelieve A.M. Tytgat
Godelieve A.M. Tytgat
HJHugo W.A.M. de Jong
Hugo W.A.M. de Jong

1 January 2016 in Radiology
Verified
Journal Article
Closed access
CBCasper Beijst
Casper Beijst
MEMattijs Elschot
Mattijs Elschot
MVMax A. Viergever
Max A. Viergever
HJHugo W. A. M. de Jong
Hugo W. A. M. de Jong
To investigate the technical feasibility of hybrid simultaneous fluoroscopic and nuclear imaging. An x-ray tube, an x-ray detector, and a gamma camera were positioned in one line, enabling imaging of the same field of view. Since a straightforward combination of these elements would block the lines of view, a gamma camera setup was developed to be able to view around the x-ray tube. A prototype was built by using a mobile C-arm and a gamma camera with a four-pinhole collimator. By using the prototype, test images were acquired and sensitivity, resolution, and coregistration error were analyzed. Nuclear images (two frames per second) were acquired simultaneously with fluoroscopic images. Depending on the distance from point source to detector, the system resolution was 1.5-1.9-cm full width at half maximum, the sensitivity was (0.6-1.5) × 10(-5) counts per decay, and the coregistration error was -0.13 to 0.15 cm. With good spatial and temporal alignment of both modalities throughout the field of view, fluoroscopic images can be shown in grayscale and corresponding nuclear images in color overlay. Measurements obtained with the hybrid imaging prototype device that combines simultaneous fluoroscopic and nuclear imaging of the same field of view have demonstrated the feasibility of real-time simultaneous hybrid imaging in the intervention room.

6 November 2019 in Pediatric Radiology
Verified
Journal Article
Open access
PDF file
CBCasper Beijst
Casper Beijst
Jeroen DudinkJeroen Dudink
Jeroen Dudink
RWRens Wientjes
Rens Wientjes
IBIsabel Benavente-Fernandez
Isabel Benavente-Fernandez
FGFloris Groenendaal
Floris Groenendaal
LVLinda S. de Vries
Linda S. de Vries
Background: Post-haemorrhagic ventricular dilatation can be measured accurately by MRI. However, two-dimensional (2-D) cranial US can be used at the bedside on a daily basis. Objective: To assess whether the ventricular volume can be determined accurately using US. Materials and methods: We included 31 preterm infants with germinal matrix intraventricular haemorrhage. Two-dimensional cranial US images were acquired and the ventricular index, anterior horn width and thalamo-occipital distance were measured. In addition, cranial MRI was performed. The ventricular volume on MRI was determined using a previously validated automatic segmentation algorithm. We obtained the correlation and created a linear model between MRI-derived ventricular volume and 2-D cranial US measurements. Results: The ventricular index, anterior horn width and thalamo-occipital distance as measured on 2-D cranial US were significantly associated with the volume of the ventricles as determined with MRI. A general linear model fitted the data best: ∛ventricular volume (ml) = 1.096 + 0.094 × anterior horn width (mm) + 0.020 × thalamo-occipital distance (mm) with R2 = 0.831. Conclusion: The volume of the lateral ventricles of infants with germinal matrix intraventricular haemorrhage can be estimated using 2-D cranial US images by application of a model.

5 February 2015 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
CBCasper Beijst
Casper Beijst
MEMattijs Elschot
Mattijs Elschot
MVMax A. Viergever
Max A. Viergever
HJHugo W.A.M. de Jong
Hugo W.A.M. de Jong
In single photon emission computed tomography (SPECT) using high-energy photon emitting isotopes, such as I-131, parallel hole collimators with thick septa are required to limit septal penetration at the cost of sensitivity and resolution. This study investigates a parallel hole collimator with cone shaped holes, which is designed to limit collimator penetration while preserving resolution and sensitivity. The objective is to demonstrate that a single slice prototype of the Parallel Cone (PC) collimator is capable of improving the image quality of high-energy SPECT. Methods: The image quality of the PC collimator was quantitatively compared to that of clinically used Low-Energy High-Resolution (LEHR; for Tc-99m) and High-Energy General-Purpose (HEGP; for I-131 and F-18) parallel hole collimators. First, Monte Carlo simulations of single and double point sources were performed to assess sensitivity and resolution by comparing point spread functions (PSFs). Second, a prototype PC collimator was used in an experimental phantom study to assess and compare contrast recovery coefficients and image noise. Results: Monte Carlo simulations showed reduced broadening of the PSF due to collimator penetration for the PC collimator as compared with the HEGP collimator (e.g. 0.9 cm vs. 1.4 cm FWHM for I-131). Simulated double point sources placed 2 cm apart were separately detectable for the PC collimator, whereas this was not the case for I-131 and F-18 at distances from the collimator face ≥10 cm for the HEGP collimator. The sensitivity, measured over the simulated profiles as the total amount of counts per decay, was found to be higher for the LEHR and HEGP collimators than for the PC collimator (e.g. 3.1x10-5 vs. 2.9x10-5 counts per decay for I-131). However, at equal noise level, phantom measurements showed that contrast recovery coefficients were similar for the PC and LEHR collimators for Tc-99m, but that the PC collimator significantly improved the contrast recovery coefficients as compared with the HEGP collimator for I-131 and F-18. Conclusion: High-energy SPECT imaging with a single slice prototype of the proposed PC collimator has shown the potential for significantly improved image quality in comparison with standard parallel hole collimators.

26 July 2023 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Open access
PDF file
RMRutger Mahieu
Rutger Mahieu
BTBernard M. Tijink
Bernard M. Tijink
RERobert J. J. van Es
Robert J. J. van Es
BNBastiaan J. van Nierop
Bastiaan J. van Nierop
CBCasper Beijst
Casper Beijst
Remco De BreeRemco De Bree
Remco De Bree
Purpose: Evaluating the Crystal Cam handheld gamma-camera for preoperative and intraoperative sentinel lymph node (SLN) localization in early-stage oral cancer. Methods: The handheld gamma-camera was used complementary to conventional gamma-probe guidance for intraoperative SLN localization in 53 early-stage oral cancer patients undergoing SLN biopsy. In 36 of these patients, a blinded comparison was made between preoperative handheld gamma-camera and lymphoscintigraphy outcomes. Of those, the reliability for marking the SLN’s location using both handheld gamma-camera and a 57Co-penpoint marker was evaluated in 15 patients. Results: In the entire cohort, the handheld gamma-camera preoperatively detected 116/122 (95%) of SLNs identified by lymphoscintigraphy. In those patients where the observer was blinded for lymphoscintigraphy (n = 36), 71/77 (92%) SLNs were correctly identified by handheld gamma-camera. Overlooked SLNs by handheld gamma-camera were mainly located near the injection site. The SLN’s marked location by handheld gamma-camera and 57Co-penpoint marker was considered accurate in 42/43 (98%) SLNs. The intraoperative use of the handheld gamma-camera led to the extirpation of 16 additional ‘hot’ lymph nodes in 14 patients, 4 of which harbored metastases, and prevented 2 patients (4%) from being erroneously staged negative for nodal metastasis. In those with follow-up ≥ 24 months or false-negative outcomes < 24 months following SLNB, a sensitivity of 82% and negative predictive value of 93% was obtained. Conclusion: The Crystal Cam handheld gamma-camera offers reliable preoperative and intraoperative SLN localization and might reduce the risk of missing a malignant SLN during surgery. Detecting SLNs near the injection site by handheld gamma-camera remains challenging.